American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15–33.

Article  Google Scholar 

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. Erratum to “IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045” [Diabetes Res. Clin. Pract. 183 (2022) 109119]. Diabetes Res Clin Pract. 2023; 204:110945.

Nathan DM. Diabetes: advances in diagnosis and treatment. JAMA. 2015;314(10):1052–62.

Article  CAS  PubMed  Google Scholar 

Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239–51.

Article  CAS  PubMed  Google Scholar 

Abdelalim EM. Modeling different types of diabetes using human pluripotent stem cells. Cell Mol Life Sci. 2021;78(6):2459–83.

Article  CAS  PubMed  Google Scholar 

Sneddon JB, Tang Q, Stock P, Bluestone JA, Roy S, Desai T, et al. Stem cell therapies for treating diabetes: progress and remaining challenges. Cell Stem Cell. 2018;22(6):810–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230–8.

Article  CAS  PubMed  Google Scholar 

Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355(13):1318–30.

Article  CAS  PubMed  Google Scholar 

Memon B, Abdelalim EM. Toward precision medicine with human pluripotent stem cells for diabetes. Stem Cells Transl Med. 2022;11(7):704–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sim EZ, Shiraki N, Kume S. Recent progress in pancreatic islet cell therapy. Inflamm Regen. 2021;41(1):1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ingulli E. Mechanism of cellular rejection in transplantation. Pediatr Nephrol. 2010;25(1):61-74. https://doi.org/10.1007/s00467-008-1020-x.

Article  PubMed  PubMed Central  Google Scholar 

Robinson J, Barker DJ, Marsh SGE. 25 years of the IPD-IMGT/HLA database. HLA. 2024;103(6): e15549.

Article  PubMed  Google Scholar 

Tak W. Mak, Mary E. Saunders, Jett BD. Chapter 6 - The Major Histocompatibility complex. Academic Cell. 2014(Primer to the Immune Response (Second Edition)):143–59.

Li L, Dong M, Wang XG. The implication and significance of beta 2 microglobulin: a conservative multifunctional regulator. Chin Med J Engl. 2016;129(4):448–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campbell KS, Purdy AK. Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology. 2011;132(3):315–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanna S, Etzioni A. MHC class I and II deficiencies. J Allergy Clin Immunol. 2014;134(2):269–75.

Article  CAS  PubMed  Google Scholar 

Haruta M, Tomita Y, Yuno A, Matsumura K, Ikeda T, Takamatsu K, et al. TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells. Gene Ther. 2013;20(5):504–13.

Article  CAS  PubMed  Google Scholar 

Giroux M, Schmidt M, Descoteaux A. IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha. J Immunol. 2003;171(8):4187–94.

Article  CAS  PubMed  Google Scholar 

Quesada-Masachs E, Zilberman S, Rajendran S, Chu T, McArdle S, Kiosses WB, et al. Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes. Diabetologia. 2022;65(2):387–401.

Article  CAS  PubMed  Google Scholar 

Crux NB, Elahi S. Human leukocyte antigen (HLA) and immune regulation: how do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections? Front Immunol. 2017;8:832.

Article  PubMed  PubMed Central  Google Scholar 

Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008;112(5):1557–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corthay A. How do regulatory T cells work? Scand J Immunol. 2009;70(4):326–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang CH, Fontes JD, Peterlin M, Flavell RA. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med. 1994;180(4):1367–74.

Article  CAS  PubMed  Google Scholar 

Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science. 1994;265(5168):106–9.

Article  CAS  PubMed  Google Scholar 

Ichiryu N, Fairchild PJ. Immune privilege of stem cells. Methods Mol Biol. 2013;1029:1–16.

Article  CAS  PubMed  Google Scholar 

Abi-Hanna D, Wakefield D, Watkins S. HLA antigens in ocular tissues. I. in vivo expression in human eyes. Transplantation. 1988;45(3):610–3.

Article  CAS  PubMed  Google Scholar 

Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol. 2006;6(8):584–94.

Article  CAS  PubMed  Google Scholar 

Levings MK, Bacchetta R, Schulz U, Roncarolo MG. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol. 2002;129(4):263–76.

Article  CAS  PubMed  Google Scholar 

Wei R, Lai N, Zhao L, Zhang Z, Zhu X, Guo Q, et al. Dendritic cells in pregnancy and pregnancy-associated diseases. Biomed Pharmacother. 2021;133: 110921.

Article  CAS  PubMed  Google Scholar 

Bamberger AM, Schulte HM, Thuneke I, Erdmann I, Bamberger CM, Asa SL. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab. 1997;82(9):3173–5.

Article  CAS  PubMed  Google Scholar 

Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature. 1995;377(6550):630–2.

Article  CAS  PubMed  Google Scholar 

Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol. 1995;154(8):3806–13.

Article  CAS  PubMed  Google Scholar 

Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity. 1996;5(1):7–16.